Synapse Biomedical

Synapse Biomedical Inc. is a medical technology company based in Oberlin, Ohio, founded in September 2002. The company focuses on the research, development, and commercialization of neurostimulation products aimed at improving respiratory function in patients with chronic respiratory insufficiency. Their flagship product, the NeuRx® Diaphragm Pacing System (DPS), was developed through a 20-year collaboration with Case Western Reserve University, University Hospitals Case Medical Center, and the Veterans Administration Medical Center. The NeuRx DPS electrically stimulates the diaphragm muscle to assist or replace mechanical ventilation for patients with respiratory insufficiency due to conditions like spinal cord injury and Amyotrophic Lateral Sclerosis (ALS). This technology helps clinicians provide diaphragm conditioning and reduce reliance on mechanical ventilators, enhancing patient outcomes. Synapse Biomedical also offers TransAeris, a minimally invasive diaphragm pacing system. The company serves healthcare providers and patients affected by neurological impairments, working closely with clinicians to integrate their technology into patient care.

• Employees32
• Founded2002
• Annual Revenue$6000000
• Total Funding$3103358